Related Experiment Videos
[A case of alternating hemiplegia in infancy--ictal SSEP findings]
No to Hattatsu = Brain and Development
|September 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dynamics of prognostic nutritional index before and after surgery in head and neck cancer.
European annals of otorhinolaryngology, head and neck diseases·2026
A 5-year longitudinal study of association of maximum bite force with development of frailty in community-dwelling older adults.
Journal of oral rehabilitation·2017
Five-year yield variation in N-nitrosonornicotine and (4-methylnitrosoamino)-1-(3-pyridyl)-1-butanone from the smoke of commercial cigarette brands on the Japanese market.
Regulatory toxicology and pharmacology : RTP·2015
Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society·2014
[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
No to hattatsu = Brain and development·2018
[Clinical characteristics of early juvenile GM2 gangliosidosis: a case report].
No to hattatsu = Brain and development·2018
[Non-invasive positive pressure ventilation during the management of severe spinal muscular atrophy type I].
No to hattatsu = Brain and development·2018
[Ictal arterial spin labeling MRI findings in two cases of acute confusional migraine].
No to hattatsu = Brain and development·2018
[A case of West syndrome with a deletion at chromosome 2q24.3-q31.3].
No to hattatsu = Brain and development·2018
[Irreversible cerebral ischemia caused by febrile status epilepticus in Sturge-Weber syndrome type III].
No to hattatsu = Brain and development·2018
Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.
Pharmaceuticals (Basel, Switzerland)·2026
Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026